Doctors Prescribing THC or CBD
To identify reputable US-based doctors (or Canada) who have publicly prescribed or supported the prescription of CBD- or THC — based products as well as any brand marketing materials, case studies, or articles that help portray how they went about marketing this to the public.
- "To date, the FDA has not approved a marketing application for cannabis for the treatment of any disease or condition."
- However, the FDA "has approved one cannabis-derived and three cannabis-related drug products." These are Epidiolex, Marinol and Syndros, and Cesamet, which are only available with a prescription from a licensed healthcare provider.
- "There are no other FDA-approved drug products that contain CBD."
- The FDA’s drug approval process includes a careful review through controlled clinical trials that test the safety and efficacy of a drug and is the most appropriate way to bring cannabis-derived treatments to patients.
- The FDA has not approved "Nabiximols (Sativex), an oral spray with two cannabinoids (THC and CBD), but it is endorsed by the American Academy of Neurology for treatment of spasticity (muscle rigidity) and nerve pain in patients with multiple sclerosis."
- "FDA has approved Epidiolex, which contains a purified form of the drug substance CBD for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older."
- This particular drug product is described as safe and effective for its intended use, based on FDA approval.
- Epidiolex was approved because of well-controlled clinical studies and the assurance of manufacturing quality standards. Doctors can "confidently prescribe this drug to treat patients with complex and serious epilepsy syndromes."
- The United States FDA has also approved "Marinol and Syndros for therapeutic uses, including the treatment of anorexia associated with weight loss in AIDS patients."
- Marinol is also approved for chemotherapy-induced nausea and vomiting.
- "Marinol and Syndros include the active ingredient dronabinol, a synthetic delta-9- tetrahydrocannabinol (THC) which is considered the psychoactive component of cannabis."
- Cesamet is another FDA-approved drug, which "contains the active ingredient nabilone, which has a chemical structure similar to THC and is synthetically derived."
- Dr. Sharon Orrange, MD, MPH
is an "Associate Professor of Clinical Medicine in the Division of Geriatric, Hospitalist and General Internal Medicine at the Keck School of Medicine of USC." She is also an Internal Medicine specialist. She has written articles about Cesamet, Marinol, Syndros, and Epidiolex.
- Dr. Gary Cohan, MD
has specialties and subspecialties in Internal Medicine, General Internal Medicine, Addiction Medicine, HIV/AIDS Medicine, and others.
- Dr. David Smith is an HIV specialist who founded the Haight-Ashbury Free Clinics in San Francisco. His specialties and subspecialties are in Infectious Disease, General Infectious Disease, and HIV/AIDS Medicine.
- Dr. Lonnie Bristow, was the first African American president of the American Medical Association (AMA). He specializes in Internal Medicine and was also an appointed member of the Centers for Disease Control Advisory Committee on the Prevention of HIV Infection from 1987 to 94.
- Drs. Cohan, Smith, and Bristow have all advocated the use of Marinol.
Proposed next steps:
You need to be the project owner to select a next step.